These findings expanded on these studies showing that the important effects of systemic dose of GLP-1 receptor agonists on addiction-like behaviors in preclinical model of cocaine use disorder (Graham et al., 2013; Hernandez et al., 2018). This evidence concerns the gene GLP1R and cocaine use disorder.